Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an ...
431.44 +12.19 (+2.91%) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈